Shionogi & Co., Ltd. (SGIOY) Q1 2025 Earnings Call Transcript

2025-07-29 08:35:31 ET

Shionogi & Co., Ltd. (SGIOY)

Q1 2025 Earnings Conference Call

July 28, 2025 03:30 AM ET

Company Participants

John A. Keller - Senior Exec. Officer, SVP of R&D Supervisory Unit and Pharma. Tech. Research Div. & Director

Masako Kudou - Corporate Officer & SVP of Corporate Strategy Division

Takeki Uehara - Corporate Officer and SVP of Drug Development & Regulatory

Takuji Fujiwara - VP, Finance & Accounting Department

Toshinobu Iwasaki - Senior Executive Officer & SVP of

Healthcare Business Supervisory Unit - Corporate Participant

Yoshimasa Kyokawa - Vice President of Corporate Communications & Secretary Office

Conference Call Participants

Akinori Ueda - Goldman Sachs Group, Inc., Research Division

Fumiyoshi Sakai - UBS Securities., Research Division

Hidemaru Yamaguchi - Citigroup Inc., Research Division

Miki Sogi - Bernstein, Research Division

Seiji Wakao - JPMorgan Chase & Co, Research Division

Shinichiro Muraoka - Morgan Stanley, Research Division

Presentation

Yoshimasa Kyokawa

Thank you all very much for joining us today despite your busy schedules. My name is Kyokawa, Vice of President of Corporate Communications Department of SHIONOGI. We are starting SHIONOGI & Co., Ltd.’s financial results briefing for the first quarter of fiscal 2025.

First of all, I would like to introduce today's speakers. John Keller, Director of the Board, Senior Vice President, R&D Supervisory Unit....

Read the full article on Seeking Alpha

For further details see: